Sofinnova Partners, an independent venture capital firm based in Paris, led a $35m seed funding round in Bioptimus, a company building the first AI foundation model for biology, with participation from Bpifrance Large Venture, Cathay Innovation, NJF Capital, Frst, Headline, Hummingbird Ventures, Owkin and Top Harvest Capital. “Foundation models in biology are game-changers. They unlock unprecedented potential to personalize medicine, capturing the uniqueness of each individual while harnessing the collective knowledge of all. Bioptimus stands out by seamlessly blending unparalleled data resources and access, elite talent, and extensive computational power. Together with Sofinnova's deep expertise in life sciences and our expansive network, we're poised to redefine the future of the industry," Edward Kliphuis, Sofinnova Partners' Partner.